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Abstract
Bats are natural reservoirs for a spectrum of infectious zoonotic diseases including the recently emerged henipaviruses
(Hendra and Nipah viruses). Henipaviruses have been observed both naturally and experimentally to cause serious and
often fatal disease in many different mammal species, including humans. Interestingly, infection of the flying fox with
henipaviruses occurs in the absence of clinical disease. The extreme variation in the disease pattern between humans and
bats has led to an investigation into the effects of henipavirus infection on the innate immune response in bat cell lines. We
report that henipavirus infection does not result in the induction of interferon expression, and the viruses also inhibit
interferon signaling. We also confirm that the interferon production and signaling block in bat cells is not due to differing
viral protein expression levels between human and bat hosts. This information, in addition to the known lack of clinical signs
in bats following henipavirus infection, suggests that bats control henipavirus infection by an as yet unidentified
mechanism, not via the interferon response. This is the first report of henipavirus infection in bat cells specifically
investigating aspects of the innate immune system.
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Introduction
Bats have been identified as the natural reservoir hosts of many
human and animal pathogens of medical importance, including a
spectrum of infectious zoonotic agents such as Ebola virus [1],
SARS coronavirus [2,3], Nipah virus [4,5] and Hendra virus [6].
Bats are considered one of the more ancient mammals, but little is
known about their immune system and how they manage
infections. Although bats harbour a large number of emerging
pathogens, they rarely show any signs of disease [1,7,8,9,10,11].
An example of this is Hendra virus in Australian fruit bats; there is
high seroprevalence in the absence of clinical signs suggesting that
there is no disease in bats associated with this virus. The nature of
persistent, non-clinical, infections and the mechanism of trans-
mission of viruses between bats and from bat to humans and other
mammals remains largely unknown. The ability of bats to harbour
highly pathogenic viruses, in the absence of significant clinical
disease or pathology is driving research into further understanding
bat biology, immunology and ecology.
Hendra virus (HeV) and Nipah virus (NiV), from the genus
Henipavirus, are highly pathogenic viruses that are harboured in
pteropodid bats. HeV has occasionally been observed to transmit to
and cause disease in horses and then have the ability to infect
humans [12,13,14,15,16,17,18,19]. The single NiV outbreak in
Malaysia (NiV-M) occurred followingspill-over of virus from bats to
pigs, with subsequent transmission from pigs to pig handlers, but no
evidence of human to human transmission [20,21,22,23,24]. The
situationinBangladesh (NiV-B)is differentwith directbatto human
transmission of NiV, followed by human to human transmission
[25,26,27,28]. Serological evidence for henipavirus infection in bats
has been reported in the geographic range spanning Australia [29],
Malaysia [30], Thailand [31,32], Cambodia [33], Indonesia [34],
Bangladesh [27], India [35], People’s Republic of China [36],
Papua New Guinea [37], Madagascar [38] and Ghana [39].
Henipaviruseshavebeenisolatedfrom flyingfoxes inAustralia[40],
Malaysia [30] and Cambodia [33], and molecular surveys have also
identified henipavirus-related RNA in African bats [41].
There are two commercially available bat cell lines, Tb1-Lu
(ATCC number CCL-88, derived from the lung of the Tadarida
brasiliensis) and the Mvi/It (ATCC number CRL-6012, established
from an interscapular tumour of Myotis velifer incautus). However,
neither cell line is susceptible to henipavirus infection (Crameri
and Wang, unpublished). Therefore there was a need to establish
Pteropus alecto cell lines which, coupled with the development of
molecular immunological tools, provide the necessary foundation
to further investigate infection by henipavirus in its natural
reservoir [42]. As fruit bats are implicated as the reservoir of many
RNA viruses, such as henipaviruses and many bat rubulaviruses
[37,43,44,45], cell lines from this genus may provide new and
important insights into virus-host interactions. P. alecto cell lines
have been established [42] and are a tool that we are using to look
at henipavirus infection in bats as a reservoir species.
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undertaken, including research into the bat toll-like receptors [46],
the characterisation of immunoglobulin heavy chain diversity [47]
and investigation into type III interferons [48]. The interferon
alpha (IFN-a) and beta (IFN-b) genes have been identified in two
species of fruit bat, the Egyptian Rousette, Rousettus aegyptiacus
[49,50] and the Malaysian flying fox, Pteropus vampyrus [51]. The
IFN-a gene has also been described in the Greenish Naked-backed
fruit bat, Dobsonia viridis [52]. The STAT1 protein has also been
identified in R. aegyptiacus and has the ability to phosphorylate and
localize to the nucleus [53]. Similar to that observed in human
cells, the function of STAT1 from R. aegyptiacus was antagonized
during infection with Rabies virus [53]. Bat research to date has
provided evidence to suggest that bats have a functional interferon
system including signaling pathways that are similar to humans
and other mammals.
Investigating the interferon genes and the regulation of innate
immunity in bats has previously not been possible due to limited
information and a lack of bat-specific immunological reagents.
Limited molecular tools have been designed for the P. alecto
species, and have shown that the interferon production pathway is
functional in bat cells [42]. The type I interferons are secreted
from most cells in response to virus infection and then bind to the
interferon specific receptors in order to activate the expression of
numerous interferon stimulated genes (ISGs), many of which have
antiviral activities (reviewed in [54]).
In addition to the type I interferons, type III interferons are a
relatively recently identified family of interferons that display similar
antiviral activity to type I interferons but signal through a distinct
receptor complex. The Type III interferon family includes three
cytokinemembersidentifiedinhumans:IFN-l1, IFN-l2a n dI F N - l3
and are also known as IL-29, IL-28A and IL-28B respectively
[55,56]. In addition, type III interferons have been identified in other
mammals, including two IFN-l genes (IL-29 and IL28B) in P. alecto
[48]. Recently we reported that P. alecto cells infected with the bat
paramyxovirus, Tioman virus, are capable of a type III interferon
response despite the suppression of type I interferons [48]. Similar to
bats, simultaneous induction of type III interferons and suppression of
type I interferons have also been reported in human cell lines infected
with hantaviruses [57]. As the IFN-l family of cytokines elicits a
similar antiviral response to that of the type I interferons, it would be
interesting to know whether the induction of IFN-l is prevented by
the evasion strategies used by henipaviruses (or other viruses), which
are known to antagonize the IFN-a/b response.
Most viruses, including the henipaviruses, express one or more
interferon antagonist proteins which suppress host interferon produc-
tion and/or signaling pathways. In this study we have conducted in vitro
infection studies at biosecurity level 4 (BSL-4), specifically for the
purpose of understanding the antagonism of the interferon pathways
following henipavirus infection in P. alecto cells. We previously reported
that interferon production is antagonized in human cells following
infection with henipaviruses, while the interferon signaling pathway
remains functional [58]. Here we report that henipavirus infection
antagonises both interferon induction and signaling in bat cells, thus
providing evidence for a significant difference in the antiviral response
to henipavirus infection between bats and humans.
Methods
Cell culture and viruses
Bat cells used for this study were previously generated from P.
alecto as described in Crameri et al [42]. Cells used include
PaLuT02 (clonal P. alecto lung cells immortalized with SV40T),
PaFe (primary P. alecto foetus cells), PaFeT (SV40 T immortalized
P. alecto foetus cells) and PaKi (primary P. alecto kidney cells). All
bat cells were maintained in Dulbecco’s Modified Eagle’s Medium
Nutrient Mixture F-12 HAM (Sigma), which also contains 15 mM
HEPES, NaHCO3, pyridoxine and L-glutamine, with 10%
bovine calf serum (BCS, Hyclone), 100 U/ml penicillin, 100 mg/
mL streptomycin and 1.25 ug/ml of amphotericin B (Invitrogen).
All cells were maintained at 37uC with 5% CO2. Human
epidermoid carcinoma cells (HEp-2) were maintained in modified
Eagle’s Minimal Essential Medium (EMEM) supplemented with
10% BCS (Hyclone), 100 U/ml penicillin, 100 mg/mL strepto-
mycin and 1.25 ug/ml of amphotericin B (Invitrogen).
The henipavirus stocks used in this study were derived from the
following isolates: Hendra virus/Australia/Horse/1994/Hendra
(HeV), Nipah virus/Malaysia/Human/1999/PKL (NiV-M) and
Nipah virus/Bangladesh/Human/2004/Rajbari R1 (NiV-B). All
work with live Hendra and Nipah viruses was carried under BSL-4
conditions at the Australian Animal Health Laboratory (AAHL),
Geelong, Australia.
Primer Design
Oligonucleotide primers for amplification of GAPDH, IFN-a,
IFN-b, ISG54 and ISG56 were designed from the sequence data of P.
vampyrus (available in the Ensembl database and the GenBank trace
file archive using BLAST on NCBI). BLAST searches and the
analysis tools contained within the software package Clone Manager
9 Professional Edition (Scientific & Educational Software, USA) were
used to identify and analyse each gene. Nucleotide and protein
sequence alignments wereperformed with sequences from a selection
of available mammalian species and used to generate a mammalian
consensus sequence. These consensus sequences were used to design
oligonucleotide primers to direct the cloning and sequencing of the P.
alecto genes of interest. The real-time primer sequences for ISG54 are
as follows: ISG54F CTACGCCTGGGTCTACTATCAC and
ISG54R AATTGCCAGTCCGGAGGAG. The primer sequences
for GAPDH, IFN-a and IFN-b [42] and ISG56 [48] have been
previously published.
RNA extraction, reverse transcription and real-time PCR
analysis
For interferon production analysis, approximately 0.2610
6 cells
were infected with a multiplicity of infection (MOI) of 10 TCID50/
cell with HeV, NiV-M or NiV-B, and at 3 h post infection (pi), the
cells were harvested for RNA extraction (RNeasy, Qiagen). For
interferon signaling analysis, approximately 0.2610
6 cells were
infected with HeV, NiV-M or NiV-B (MOI 10). At 24 h pi, the
cells were treated with 1000 U of Universal Type I Interferon
(PBL). Universal Type I interferon is an IFN-a hybrid constructed
from recombinant human IFN-a A and human IFN-a D (Human
Interferon a A/D). 3 h post interferon treatment, the cells were
harvested, and total RNA isolated. Random primed cDNA was
reverse transcribed using SuperscriptH III Reverse Transcriptase
(Invitrogen), and quantitative Real Time PCR was performed
using SYBR Green (EXPRESS SYBRH GreenER qPCR Super-
Mix Universal, Invitrogen) in an ABI 7900 or 7500. The PCR
cycling conditions were as follows: one cycle at 95uC for 20 secs
and 40 cycles of 95uC for 3 secs and 60uC for 30 secs. Individual
mRNA transcripts were assayed in duplicate, and CT values were
used to calculate the relative fold changes in each gene. GAPDH
mRNA levels were used to normalize samples.
SDS-PAGE and Western Blot
HEp-2 cells were infected at an MOI of 1 for 24 h, and the
PaLuT02 cells were infected at an MOI 10 for 24 h. Cell lysates
were prepared and analysed as previously described [58].
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The bat cells (PaLuT02, PaFe, PaFeT, PaKi, PaLuT02) were
infected with either HeV, NiV-M or NiV-B at an MOI of 10 for
24 h. Immunofluorescence was undertaken as previously de-
scribed [58].
Results
Viral infection antagonizes interferon production in bat
cells
Virus infection induces many responses in cells, the most rapid
of which include the secretion of type I and III interferons.
Stimulation of bat cells with poly I:C results in the induction of
type I (IFN-a and IFN-b) and type III interferons (IFN-l)
[42,48,50], demonstrating that the interferon production pathways
are functional in these cells. The impact of henipavirus infection
on the interferon production pathway in bat lung cells (PaLuT02)
was analysed by investigating the regulation of IFN-a and IFN-b
mRNA transcripts in comparison to mock infected cells. To
examine the effects of henipavirus infection on the interferon
production pathway, bat lung cells (PaLuT02) were infected at an
MOI of 10 with individual henipaviruses, HeV, NiV-M and NiV-
B. After 3 h, total RNA was extracted from cells, and utilized for
real-time PCR assays to measure transcriptional regulation of
interferon genes. Transfection of 10 mg poly I:C was used as a
positive control as previously reported [42]. Following infection
both IFN-a and IFN-b mRNA transcripts were comparable to
that observed in mock infected cells (Figure 1a). This suggests that
the interferon production pathway is antagonized by each of the
three tested henipaviruses, which is comparable to that seen in
human cells [58]. The transcriptional regulation of the ISG54 and
ISG56 genes was also investigated to confirm that there is a block
in interferon production (Figure 1b). The levels of both ISG54 and
ISG56 mRNA transcripts were equivalent to mock-infected cells,
suggesting that interferon is not produced and therefore no
stimulation of the interferon signaling pathway is observed.
In addition to type I interferons, the IFN-l genes (type III
interferons), IL-29 and IL-28B were investigated following henipa-
virus infection (Figure 1c). Following HeV and NiV-M infection, the
IFN-l transcripts were 50% of the level observed in mock infected
cells, strongly suggesting a block in IFN-l production. The levels of
IFN-l mRNA transcripts following NiV-B infection were compara-
ble with that seen in mock (Figure 1c).
Viral infection antagonizes the interferon signaling
pathway in bat cells
The effect of henipavirus infection on the interferon signaling
pathway in PaLuT02 cells was investigated by stimulation with
exogenous interferon in order to circumvent the effects of viral
antagonism on the interferon production pathway. As there are
limited bat immunology reagents available, a universal recombi-
nant human interferon alpha hybrid (PBL) was used. Cells from a
variety of mammalian species have been demonstrated to respond
to Universal Interferon, including human, monkey, mouse,
bovine, rat, cat, pig, rabbit, guinea pig and hamster [59]. Since
this product is useful for cross species testing and in cases where
autologous interferon is not available, we hypothesized that this
interferon would also be effective in bat cells. To confirm activity
of Universal Interferon on bat cells, 1000 U of Universal
Interferon was used to treat PaLuT02 cells. Upregulation of
mRNA transcripts for interferon stimulated genes ISG54 and
ISG56 were measured at different time-points. As shown in
Figure 2a, an increase in relative ISG54/56 mRNA levels
occurred over time, however for practical purposes, a 3 h time-
point was chosen for all subsequent experiments. PaLuT02 cells
were infected with individual henipaviruses HeV, NiV-M and
NiV-B at an MOI of 10 and at 24 h pi the cells were treated with
1000 U of Universal Interferon for 3 h. The cells were harvested
for RNA extraction and levels of ISG54 and ISG56 mRNA
transcripts were determined. Following interferon treatment of the
mock infected cells, the ISG54 and ISG56 were up-regulated by
approximately 16-fold and 50-fold, respectively, compared to basal
levels (Figure 2b). The untreated HeV, NiV-M and NiV-B infected
cells show no up-regulation of ISGs. Following interferon
treatment of the infected cells, there is also no significant increase
in ISG54 and ISG56 transcripts, demonstrating that interferon
signaling is also antagonized following henipavirus infection.
Immunofluorescence was undertaken to confirm that the cells
were at least 90% infected with HeV, NiV-M and NiV-B prior to
undertaking the ISG real-time assays (Figure 2c).
Due to the differences observed following henipavirus infection
and interferon signaling in bat cells compared to human cells, the
experiment was repeated in several different P. alecto cell lines.
Cells were infected with HeV in order to determine whether a
block in interferon signaling is universal or unique to the PaLuT02
cells. Primary fetus and kidney cells (PaFe and Paki), and cloned,
immortalised fetus and lung cells (PaFeT and PaLuT02) were
infected with HeV for 24 h at a high MOI and were treated with
Universal Interferon (1000 U) for 3 h prior to harvesting for real
time assays (Figure 3a). A percentage block in ISG54 and ISG56
induction was calculated with mock-infected cells being set at
100% for each cell type. In all cell types there was at least a 75–
80% reduction in ISG54/56 transcription compared to mock-
infected cells (Figure 3a). Immunofluorescent detection of
duplicate HeV infected cells confirmed a 75–80% level of
infection (Figure 3b).
Comparable levels of henipavirus proteins are expressed
in bat and human cells
Recently we reported the interferon response of human cells to
infection with henipavirus compared with transfection with NiV P,
V and W gene products. [58]. We hypothesized that the amount of
viral protein expressed may dictate the level of antagonism
observed on the interferon production and signaling pathways.
Due to the apparent differences in interferon signaling antagonism
displayed by human and bat cells infected with henipaviruses, we
investigated the protein expression levels of the P-gene products in
the two host cell types. SDS-PAGE and Western blot analysis were
performed on multiple cell lysates to investigate the ratio of the P-
gene products (P, V and W) relative to N protein expression. The
lysates prepared from human (HEp-2) and P. alecto (PaLuT02) cells
showed a decreased level of P, V and W expression in P. alecto cell
lines compared with human cells (Figure 4). The results suggest
that the block in interferon signaling in P. alecto cells is not a result
of differential expression of P-gene products.
Discussion
Recently we described the interferon response of human cells to
henipavirus infection, demonstrating a block in the induction of
the interferon production pathway, with little effect on interferon
signaling (Virtue, 2011). This contrasted with that reported
from transfected cells expressing P gene derived proteins
[60,61,62,63,64,65]. We further demonstrated that transfection
of cells with henipavirus P-gene products leads to a significant
increase in the level of protein expression in cells and, we
hypothesized that the different results could be accounted for by
viral protein levels [58]. In henipavirus infected bat cells, the
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22488Figure 1. Antagonism of type I interferon production in bat cells infected with henipaviruses. PaLuT02 cells were infected at an MOI of
10 for 3 h. Total RNA was isolated and quantitative real-time PCR was performed using SYBR Green. The (A) IFN-a and IFN-b mRNA levels and, (B)
ISG54 and ISG56 mRNA levels were detected and relative fold changes calculated. Transfection of 10 mg poly I:C was used as a positive control. N=2
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22488interferon production pathway was antagonized, similar to that
seen in human cell lines [58]. In addition to type I interferons, the
recently identified type III interferons were also suppressed in
henipavirus infected bat cells. This result contrasts with the up-
regulation of type III interferons in bat cells infected with another
bat paramyxovirus, Tioman virus. It was previously hypothesized
with error bars indicating SEM. (C) IL28B and IL29 mRNA levels were detected and relative fold changes calculated. Transfection of 10 mg poly I:C was
used as a positive control. N=2 with bars indicating variation between replicates.
doi:10.1371/journal.pone.0022488.g001
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strategy following suppression of type I interferons [48]. However,
these results demonstrate that this does not appear to be the case
during henipavirus infection.
In addition to suppression of interferon production, the
interferon signaling pathway was also antagonized in bat cell lines
following infection as demonstrated by the absence of an ISG
response. This block in interferon signaling was observed in
multiple cell lines derived from several different organs. Although
the block is not 100% following HeV infection, we hypothesize
that this is due to a small percentage of uninfected cells, and not
leaky activation of the interferon signaling pathway. This
hypothesis is reflected in the level of infected cells seen by
immunofluorescence on duplicate samples at the point of RNA
extraction. The antagonism of the interferon signaling pathway in
all cell types suggests that the block in interferon signaling is not
cell type specific, and is a universal response that would be
expected to occur in vivo in bats. Following this study, investigation
into the effect of henipavirus infection on immune cells, such as
dendritic cells, will also be undertaken.
Although interferon induction in human cell lines is inhibited by
henipavirus infection, treatment with exogenous interferon
restores the ISG response [58]. In contrast, exogenous interferon
failed to induce an ISG response in henipavirus infected bat cells,
consistent with a block in both interferon induction and signaling
pathways in bat cells. This difference was not due to different
ratios of henipavirus P-gene products expressed in bats cells
compared to human cells. Therefore, we conclude that the block
in interferon signaling in bat cells is not due to an increase in total
P gene product expression or an altered ratio of P/V/W in cells,
but due to an as yet unidentified factor. Potentially this difference
could be due to increased binding affinity of the P gene products to
the P. alecto STAT1. We previously determined that henipavirus
proteins only antagonise the interferon signaling pathway in
human cells as an artefact of overexpression systems, not during in
vitro infection studies [58]. However interaction of P/V/W with
Figure 3. Cell type-independent antagonism of the interferon signaling pathway in bat cells. (A) PaFe, PaFeT, PaKi and PaLuT02 cells
were infected with HeV at a high MOI for 24 h pi, followed by treatment with Universal Interferon (1000 U) for 3 h. Real-time PCR was then performed
for ISG54 and ISG56. N=2 with error bars indicating SEM. (B) Immunofluorescent staining of duplicate infections were undertaken to determine level
of virus infection using HeV P-specific antisera.
doi:10.1371/journal.pone.0022488.g003
Figure 2. Henipavirus infection and antagonism of the interferon signaling pathway following treatment with exogenous Universal
Interferon. (A) PaLuT02cellsweretreatedwith1000 UofUniversalInterferonandcellswereharvestedat1 h intervalsfrom1to5 h.Real-timePCRwas
then performed for ISG54, ISG56. (B) PaLuT02 cells were infected with HeV, NiV-M and NiV-B at an MOI of 10 for 24 h pi, followed by Universal Interferon
(1000 U) treatment for 3 h. Real-time PCR was then performed for ISG54, ISG56. The error bars indicate standard deviation of three independent
experiments. (C) Immunofluorescent staining of duplicate infections were undertaken to determine level of virus infection using HeV P-specific antisera.
doi:10.1371/journal.pone.0022488.g002
Henipaviruses Antagonize IFN Response in Bat Cells
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the antagonism of the interferon signaling pathways during single
gene studies [66,67,68,69].
These results highlight a difference in henipavirus-host interactions
between bats (natural reservoirhost) and humans (spill-over host,with
a fatal outcome). Transcription and expression of ISGs results in the
generation of an antiviral state in cells, preventing infection and
replication of virus in neighbouring cells.Blocking both the interferon
production and signaling pathways is the optimal mechanism for a
virus to counteract the host response. If the production pathway is
blocked, no interferon is secreted. However, professional antigen
presenting cells such as dendritic cells are programmed to produce
large amounts of interferon, which may not be prevented by viral
interferon antagonist proteins. Blocking the signaling pathway in this
situation is insurance, as the virus can block the effect of interferon.
Blocking both pathways is considered to give the virus a strong
advantage over the hostand would be expected to allow for improved
infection in the host where this is possible. The ability of henipavirus
to block interferon induction and signaling in bat cells is surprising
given the asymptomatic nature of henipavirus infection in bats
compared with humans, which have an intact signaling response but
generally fatal response to infection. This would suggest that bats
control henipavirus infection by an as yet unidentified mechanism,
not via the interferon response. Given the importance of the
interferon response in controlling vi r a lr e p l i c a t i o ni no t h e rm a m m a l s ,
this result is significant, providing evidence for differences in the
antiviral response of bats compared to humans.
In this study, we have shown that henipaviruses block interferon
production in bat cells. We have also demonstrated differences in
the ability of the henipaviruses to block the interferon signaling
pathway in bat cells compared with human cells and this block is
not due to an increased level of viral protein expression. We
hypothesize that the interferon response is not responsible for the
differences in the susceptibility of bats and humans to henipavirus
infection. Identification of the mechanism by which bats control
viral infections has the potential to direct research in the
development of new, broadly active antiviral strategies. This study
has added to the reported investigations into virus-bat interaction
and bat immunology in general.
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